BioRestorative Therapies, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.56 | -$0.48 | -$0.52 |
| Q2 2024 | 1 | -$0.62 | -$0.52 | -$0.57 |
| Q3 2024 | 1 | -$0.47 | -$0.40 | -$0.43 |
| Q4 2024 | 1 | -$0.30 | -$0.25 | -$0.28 |
| Q1 2025 | 1 | -$0.28 | -$0.24 | -$0.26 |
| Q2 2025 | 1 | -$0.22 | -$0.18 | -$0.20 |
| Q3 2025 | 1 | -$0.22 | -$0.18 | -$0.20 |
| Q4 2025 | 1 | -$0.23 | -$0.19 | -$0.21 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
BioRestorative Therapies, Inc. Earnings Date And Information
BioRestorative Therapies, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.5 earnings per share for the quarter, topping analysts' consensus estimates of $-0.56 by $0.06. The company had revenue of 233,600 for the quarter and had revenue of 145,800 for the year. BioRestorative Therapies, Inc. has generated $-2 earnings per share over the last year ($-2.47 diluted earnings per share) and currently has a price-to-earnings ratio of -1.95. BioRestorative Therapies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
BioRestorative Therapies, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$0.13 | $333,333 | $233,600 | ||
| 08/13/2024 | Q2 2024 | -$0.56 | -$0.50 | 0.06 | $10,000 | $89,100 |
| 06/11/2024 | Q1 2024 | -$0.51 | -$0.33 | 0.18 | $35,000 | |
| 06/11/2024 | Q4 2023 | -$0.51 | $0.25 | 0.76 | $19,300 | |
| 11/13/2023 | Q3 2023 | -$0.68 | -$0.02 | 0.66 | $30,000 | $30,700 |
| 08/11/2023 | Q2 2023 | -$1.56 | -$0.77 | 0.79 | $65,000 | $64,500 |
| 05/12/2023 | Q1 2023 | -$1.26 | -$1.51 | -0.25 | $31,300 | |
| 03/24/2023 | Q4 2022 | -$1.04 | $3,700 | |||
| 11/14/2022 | Q3 2022 | -$0.49 | -$1.29 | -0.8 | $29,000 | |
| 08/15/2022 | Q2 2022 | -$0.55 | -$1.30 | -0.75 | $71,100 | |
| 05/13/2022 | Q1 2022 | -$0.63 | -$1.30 | -0.67 | $16,000 | |
| 03/30/2022 | Q4 2021 | -$0.54 | -$23.39 | -22.85 | $5,000 | |
| 11/15/2021 | Q3 2021 | -$4.99 | $8,000 | $8,000 | ||
| 08/16/2021 | Q2 2021 | -$5.10 | $15,000 | |||
| 05/17/2021 | Q1 2021 | -$19.72 | $18,000 | |||
| 04/29/2021 | Q4 2020 | -$7.26 | $17,000 | |||
| 04/12/2021 | Q3 2020 | -$2.10 | $15,000 | |||
| 04/12/2021 | Q2 2020 | $7.21 | $19,000 | |||
| 03/29/2021 | Q1 2020 | -$18.94 | $26,000 | |||
| 03/17/2021 | Q4 2019 | -$3.89 | $32,000 |
BioRestorative Therapies, Inc. Earnings: Frequently Asked Questions
-
When is BioRestorative Therapies, Inc.'s earnings date?
BioRestorative Therapies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
Did BioRestorative Therapies, Inc. beat their earnings estimates last quarter?
In the previous quarter, BioRestorative Therapies, Inc. (:BRTX) reported $-0.5 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.56 by $0.06.
-
How can I listen to BioRestorative Therapies, Inc.'s earnings conference call?
The conference call for BioRestorative Therapies, Inc.'s latest earnings report can be listened to online.
-
How can I read BioRestorative Therapies, Inc.'s conference call transcript?
The conference call transcript for BioRestorative Therapies, Inc.'s latest earnings report can be read online.
-
How much revenue does BioRestorative Therapies, Inc. generate each year?
BioRestorative Therapies, Inc. (:BRTX) has a recorded annual revenue of $145,800.
-
How much profit does BioRestorative Therapies, Inc. generate each year?
BioRestorative Therapies, Inc. (:BRTX) has a recorded net income of $145,800. BioRestorative Therapies, Inc. has generated $-2.47 earnings per share over the last four quarters.
-
What is BioRestorative Therapies, Inc.'s price-to-earnings ratio?
BioRestorative Therapies, Inc. (:BRTX) has a price-to-earnings ratio of -1.95 and price/earnings-to-growth ratio is 0.11.
